These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 25196155)
1. Neuroprotection for ischaemic stroke: current status and challenges. Moretti A; Ferrari F; Villa RF Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155 [TBL] [Abstract][Full Text] [Related]
2. Emerging neuroprotective drugs for the treatment of acute ischaemic stroke. Schmidt A; Minnerup J; Kleinschnitz C Expert Opin Emerg Drugs; 2013 Jun; 18(2):109-20. PubMed ID: 23600899 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches. Wahlgren NG; Ahmed N Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293 [TBL] [Abstract][Full Text] [Related]
4. [Past, present and future of neuroprotection]. Mracek J Cas Lek Cesk; 2010; 149(12):586-90. PubMed ID: 21387585 [TBL] [Abstract][Full Text] [Related]
5. [In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies]. Lestage P; Lockhart B; Roger A Therapie; 2002; 57(6):554-63. PubMed ID: 12666263 [TBL] [Abstract][Full Text] [Related]
6. The past and future of neuroprotection in cerebral ischaemic stroke. Shuaib A; Hussain MS Eur Neurol; 2008; 59(1-2):4-14. PubMed ID: 17917451 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological therapy of acute ischaemic stroke: Achievements and problems. Moretti A; Ferrari F; Villa RF Pharmacol Ther; 2015 Sep; 153():79-89. PubMed ID: 26079382 [TBL] [Abstract][Full Text] [Related]
8. Inhalation gases or gaseous mediators as neuroprotectants for cerebral ischaemia. Sutherland BA; Harrison JC; Nair SM; Sammut IA Curr Drug Targets; 2013 Jan; 14(1):56-73. PubMed ID: 23170797 [TBL] [Abstract][Full Text] [Related]
10. Thrombolysis and neuroprotection in cerebral ischemia. Gutiérrez M; Díez Tejedor E; Alonso de Leciñana M; Fuentes B; Carceller F; Roda JM Cerebrovasc Dis; 2006; 21 Suppl 2():118-26. PubMed ID: 16651822 [TBL] [Abstract][Full Text] [Related]
11. Time is Penumbra: imaging, selection and outcome. The Johann jacob wepfer award 2014. Davis S; Donnan GA Cerebrovasc Dis; 2014; 38(1):59-72. PubMed ID: 25227260 [TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke. Timsit S; Menn B Clin Pharmacol Ther; 2012 Feb; 91(2):327-32. PubMed ID: 22218073 [TBL] [Abstract][Full Text] [Related]
13. Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention. Broussalis E; Killer M; McCoy M; Harrer A; Trinka E; Kraus J Drug Discov Today; 2012 Apr; 17(7-8):296-309. PubMed ID: 22134007 [TBL] [Abstract][Full Text] [Related]
17. Drug therapy in stroke: from preclinical to clinical studies. Kaur H; Prakash A; Medhi B Pharmacology; 2013; 92(5-6):324-34. PubMed ID: 24356194 [TBL] [Abstract][Full Text] [Related]
18. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies. Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898 [TBL] [Abstract][Full Text] [Related]
19. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis. Köhrmann M; Schellinger PD; Schwab S Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867 [TBL] [Abstract][Full Text] [Related]